abstract |
The present invention provides a large human 2 'for diagnosing, preventing, and treating infections with positive-sense single-chain RNA viruses, and for predicting human genetic sensitivity to positive-sense single-chain RNA virus-related diseases. And a 5'-oligoadenylate synthetase (OAS3). |